Do not vaccinate unhealthy birds.
Do not use in birds in lay.
It is accepted that spray administration offers benefits over water administration in terms of ease of application and percentage of birds vaccinated. Nevertheless, greater secondary problems can result under certain management conditions. Spray vaccination should not be used if inter-current infection is suspected.
Safety and efficacy data are available which demonstrate that this vaccine, when administered by eye drop at one day of age, can be administered on the same day as Poulvac IBMM and Poulvac MD Vac administered by eye drop and by injection, respectively, and that Poulvac Bursine 2 may be administered by eye drop within 7 days.
Safety and efficacy data are available which demonstrate that this vaccine, when administered by eye drop at 4 weeks of age, can be administered on the same day as Poulvac ILT, Poulvac AE and Poulvac Bursine 2 by eye drop.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Safety and efficacy data are available which demonstrates that this vaccine can be mixed and administered with Poulvac IBMM, Poulvac ILT, Poulvac AE and Poulvac Bursine 2 when administering by eye drop. Do not mix with any other veterinary medicinal product.
Reactions to vaccination occur seldom after intranasal, intraocular or drinking water administration. Mild respiratory distress is observed in up to 4% of birds vaccinated by the spray route. These symptoms typically appear within 4 to 9 days of the administration of the vaccine and may last several days.
No adverse reactions exceeding those reported above were recorded following administration of a tenfold overdose by the oral, intranasal or eye drop routes. The administration of a tenfold overdose by the spray route results in an increased incidence of respiratory distress and may result in mortality rates of up to 8%.
Withdrawal period
Zero days
Operator warnings
Live Newcastle disease virus may cause conjunctivitis in man. When administering vaccine by the spray method operators must protect eyes and nose by wearing goggles and a mask or a full face mask that comply with BS EN 166:2002 and BS EN 149:2001.